Innovus Pharma (OTCQB: INNV), headquartered in La Jolla, California, is an emerging pharmaceuticals company that delivers innovative and uniquely presented and packaged health solutions through its over-the-counter medicines and consumer and health products.
Innovus Pharma's mission is to in-license, acquire or develop over-the-counter and consumer healthcare products designed for in-home treatment of medical conditions and ailments to help people take care of themselves and their families in order to live healthy lives. SNNLive spoke with Dr. Bassam Damaj from Innovus Pharma at the Aegis Capital Corp. Healthcare & Technology Conference 2014 in Las Vegas, NV.
Dr. Bassam begins with a brief overview of the company, “Innovus Pharma is a small-cap publicly traded company. We are the leaders in over-the-counter and consumer care products for male and female sexual dysfunction. Our lead product is Zestra, which is the only commercial product clinically proven to help women with female sexual interest arousal disorder. The product is commercially available in the US and Canada and now we’re expanding on a worldwide basis.”
Dr. Damaj states that his background was in immunology, has been a public CEO for a long time, and is, “looking forward to executing on Innovus and taking it to the next level.” For more information, check out their website at www.innovuspharma.com
© 2017 Stock News Now
Supported by Superior Web Solutions